Patterned Sensory Enhancement, a Music Rehabilitation Therapy for Elderly Patients with Neuromotor Deficit during the COVID-19 Pandemic: A Pilot Study.

Patterned Sensory Enhancement, a Music Rehabilitation Therapy for Elderly Patients with Neuromotor Deficit during the COVID-19 Pandemic: A Pilot Study.

Publication date: Dec 31, 2023

(1) Background: The Patterned Sensory Enhancement (PSE) technique refers to a music-based rehabilitation therapy strategy used in neurological pathologies. (2) Methods: This study aims at developing a music-drill protocol for recovery in elderly patients with neuromuscular degenerative pathologies. Each music drill is based on a number of specific music-composition parameters. The conclusions represent suggestions for further enhancing the PSE technique through collaborations between the rehabilitation team and the musicians involved due to the importance of the music stimuli used as a therapy. (3) Results: The music-composition parameters used in this study relate to the existence of music homogeneity factors such as the key signature and rhythm; the importance of the major scale and the tonal system in general; the obvious music suggestions of movement, repetition or absence of movement; the importance of rhythm; the introduction of musical instruments in order to harmonize the music material as much as possible; the connection between PSE music along with patients’ musical taste and the musical recording as a therapy during patient outcare; (4) Conclusions: The therapy efficiency was observed by measurements taken before and after the therapeutic intervention by means of a Takei dynamometer. The present study asserts that for a patient undergoing the PSE technique, the researcher should compose personalized music material adapted to each patient’s peculiarities.

Open Access PDF

Concepts Keywords
Covid elderly
Elderly musculoskeletal
Pandemic music therapy
Pilot neuromotor rehabilitation
Therapy relaxation


Type Source Name
disease MESH COVID-19 Pandemic
disease VO protocol
disease VO efficiency
disease IDO intervention
disease MESH Emergency
disease VO effectiveness
drug DRUGBANK Coenzyme M
disease MESH dementia
disease MESH stroke
disease MESH inflammation
disease MESH cognitive decline
disease MESH muscle strength
disease VO viable
disease MESH Alzheimer’s disease
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Profenamine
disease MESH cardiac arrhythmia
disease VO time
disease MESH sti
drug DRUGBANK N-acetylsulfanilyl chloride
drug DRUGBANK Aspartame
drug DRUGBANK Ranitidine
drug DRUGBANK Albendazole
disease VO URE
disease IDO quality
pathway REACTOME Release
drug DRUGBANK Isoxaflutole
disease IDO production
drug DRUGBANK Etoperidone
disease MESH Parkinson’s disease
disease IDO facility
disease VO frequency
disease VO population
disease VO age
disease MESH sarcopenia
pathway KEGG Parkinson disease
disease MESH clinical progression
drug DRUGBANK Gold
disease VO USA
disease IDO blood
disease VO effective
disease MESH spastic diplegia
disease MESH Gait
disease MESH Posture
disease MESH middle cerebral artery stroke

Original Article

(Visited 1 times, 1 visits today)